549 related articles for article (PubMed ID: 33679709)
1. Dendritic Cell-Based Immunotherapy in Lung Cancer.
Stevens D; Ingels J; Van Lint S; Vandekerckhove B; Vermaelen K
Front Immunol; 2020; 11():620374. PubMed ID: 33679709
[TBL] [Abstract][Full Text] [Related]
2. [Vaccines for the treatment of non-small cell lung cancer].
Leduc C; Quoix E
Rev Mal Respir; 2019 Mar; 36(3):415-425. PubMed ID: 30902445
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy and lung cancer: current developments and novel targeted therapies.
Domingues D; Turner A; Silva MD; Marques DS; Mellidez JC; Wannesson L; Mountzios G; de Mello RA
Immunotherapy; 2014; 6(11):1221-35. PubMed ID: 25496336
[TBL] [Abstract][Full Text] [Related]
4. Dendritic Cells and Their Role in Immunotherapy.
Gardner A; de Mingo Pulido Á; Ruffell B
Front Immunol; 2020; 11():924. PubMed ID: 32508825
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer.
Zhao P; Bu X; Wei X; Sun W; Xie X; Li C; Guo Q; Zhu D; Wei X; Gao D
Int Immunopharmacol; 2015 Apr; 25(2):450-6. PubMed ID: 25698555
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic vaccines explored in patients with non-small cell lung cancer.
Ma K; Tang YH
Anticancer Agents Med Chem; 2014 Feb; 14(2):256-64. PubMed ID: 24237217
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.
Anagnostou VK; Brahmer JR
Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707
[TBL] [Abstract][Full Text] [Related]
8. Increased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC.
Song H; Liu S; Zhao Z; Sun W; Wei X; Ma X; Zhao P; Gao D
Int Immunopharmacol; 2017 Nov; 52():197-202. PubMed ID: 28941416
[TBL] [Abstract][Full Text] [Related]
9. Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS).
Zhao Y; Qiao G; Wang X; Song Y; Zhou X; Jiang N; Zhou L; Huang H; Zhao J; Morse MA; Hobeika A; Ren J; Lyerly HK
Clin Transl Oncol; 2019 Jun; 21(6):721-728. PubMed ID: 30374838
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for non-small-cell lung cancer.
Thomas A; Jakopovic M
Expert Opin Biol Ther; 2014 Aug; 14(8):1061-4. PubMed ID: 24878420
[TBL] [Abstract][Full Text] [Related]
11. Current state of vaccine therapies in non-small-cell lung cancer.
Romero P
Clin Lung Cancer; 2008 Feb; 9 Suppl 1():S28-36. PubMed ID: 18540532
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
Wang S; Wang Z
Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
[TBL] [Abstract][Full Text] [Related]
13. What lies within: novel strategies in immunotherapy for non-small cell lung cancer.
Forde PM; Reiss KA; Zeidan AM; Brahmer JR
Oncologist; 2013; 18(11):1203-13. PubMed ID: 24105749
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell vaccines against non-small cell lung cancer - an emerging therapeutic alternative.
Mendoza L
Klin Onkol; 2014; 27(4):294-8. PubMed ID: 25115721
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
Delcayre A; Shu H; Le Pecq JB
Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint therapy for non-small-cell lung cancer: an update.
Xia B; Herbst RS
Immunotherapy; 2016; 8(3):279-98. PubMed ID: 26860624
[TBL] [Abstract][Full Text] [Related]
17. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Hall RD; Gray JE; Chiappori AA
Cancer Control; 2013 Jan; 20(1):22-31. PubMed ID: 23302904
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer.
Yuanying Y; Lizhi N; Feng M; Xiaohua W; Jianying Z; Fei Y; Feng J; Lihua H; Jibing C; Jialiang L; Kecheng X
Cryobiology; 2013 Oct; 67(2):235-40. PubMed ID: 23948179
[TBL] [Abstract][Full Text] [Related]
19. Is vaccine therapy a renewed strategic approach for non-small-cell lung cancer therapy?
Rossi A
Expert Rev Vaccines; 2013 Jan; 12(1):5-7. PubMed ID: 23256734
[No Abstract] [Full Text] [Related]
20. New Immunotherapy and Lung Cancer.
Sánchez de Cos Escuín J
Arch Bronconeumol; 2017 Dec; 53(12):682-687. PubMed ID: 28823733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]